Inactive Instrument

Other languages Navidea Biopharmaceuticals Inc Nyse

Equities

US63937X1037

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Sector Update: Health Care	23-10-06
Top Midday Decliners	23-10-06
Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11
Navidea Biopharmaceuticals, Inc. Announces Resignation of Malcolm G. Witter as Director, Member of the Audit Committee and Compensation, Nominating and Governance Committee of the Board	23-08-08
Navidea Biopharmaceuticals, Inc. Announces Executive Changes	23-07-28
Navidea Biopharmaceuticals, Inc. Announces Board Changes	23-07-13
Navidea Biopharmaceuticals Confirms Rejection of ProPhase Labs' Proposal to Buy Some of Its Assets	23-06-30
ProPhase Labs, Inc. cancelled the acquisition of Certain Assets from Navidea Biopharmaceuticals, Inc. for $7 million.	23-06-28
Sector Update: Health Care Stocks Steady Late Friday	23-06-16
Sector Update: Health Care	23-06-16
Navidea Biopharmaceuticals Gets $7.5 Million Payment From Cardinal Health	23-06-16
Navidea Biopharmaceuticals, Inc. Announces Board Changes	23-06-01
Navidea Biopharmaceuticals Sells Preferred Shares Worth $1.1 Million	23-05-23
Navidea Biopharmaceuticals Promotes Michael Sherman Blue to Chief Medical Officer	23-05-11
Navidea Biopharmaceuticals, Inc. Promotes Michael Sherman Blue, M.D., FACEP, to Chief Medical Officer	23-05-11
Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Navidea Biopharmaceuticals Intends to Sell Cardinal Milestone Payment	23-04-27
Navidea Biopharmaceuticals, Meilleur Technologies Sign License Deal for Alzheimer's Disease Diagnosis Agent	23-04-14
Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694	23-04-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Navidea Biopharmaceuticals Inc Nyse

Equities

US63937X1037

Other languages

Filters